Expansion4 Feb 2025, 05:02 pm
Sigachi Industries to Establish a State-of-the-art R&D Center in Hyderabad with USD 1 Million Investment
AI Summary
Sigachi Industries, a leading player in the pharmaceutical industry, is establishing a state-of-the-art R&D Center in Hyderabad, India. This strategic initiative involves an investment of up to USD 1 Million and is set to commence immediately, reinforcing Sigachi's commitment to innovation and long-term growth and efficiency. The new facility is designed to optimize API production, drive sustainable growth, nurture talent, and streamline the pharma product portfolio. Sigachi is committed to revolutionizing API development by advancing synthesis and analytical processes, and is looking to fuel additional CEP’s in the coming 6 months.
Key Highlights
- Establishing a state-of-the-art R&D Center in Hyderabad, India
- Investment of up to USD 1 Million
- Optimize API production and drive sustainable growth
- Nurture talent by employing a team of 15-20 skilled R&D scientists
- Streamline the pharma product portfolio to focus on priority API’s and Intermediates